These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 10954955

  • 1. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
    Paster RZ, McAdoo MA, Keyserling CH, Nemeth MA, Tack KJ, Griffin TJ.
    Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ.
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [Abstract] [Full Text] [Related]

  • 3. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML, Jacobson KD, Guerra FJ, Therasse DG, Farlow D.
    Clin Ther; 1992 Jan; 14(2):214-29. PubMed ID: 1611645
    [Abstract] [Full Text] [Related]

  • 4. Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis.
    Fogarty CM, Bettis RB, Griffin TJ, Keyserling CH, Nemeth MA, Tack KJ.
    J Antimicrob Chemother; 2000 Jun; 45(6):851-8. PubMed ID: 10837440
    [Abstract] [Full Text] [Related]

  • 5. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 6. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH, Farlow D, Therasse DG, Ruoff GE.
    Clin Ther; 1992 Nov; 14(1):41-53. PubMed ID: 1576625
    [Abstract] [Full Text] [Related]

  • 7. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH, Farlow D, Therasse DG, Jacobson KD, Guerra FJ.
    Clin Ther; 1992 Nov; 14(2):166-77. PubMed ID: 1611641
    [Abstract] [Full Text] [Related]

  • 8. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A, Longest KA, Senetar JE, Dere WH.
    Postgrad Med J; 1992 Nov; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [Abstract] [Full Text] [Related]

  • 9. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I, Gogos CA, Bassaris H.
    Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
    [Abstract] [Full Text] [Related]

  • 10. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC, Kapral D, Busman TA, Paris MM.
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a Phase II, multicenter, noncomparative, open-label study in adult patients undergoing sinus aspiration.
    Lopez Sisniega J, Profant M, Kostrica R, Waskin H.
    Clin Ther; 2007 Aug; 29(8):1632-44. PubMed ID: 17919545
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cefaclor af versus amoxycillin/clavulanate in acute bacterial exacerbations of chronic bronchitis: a randomised multicentre study.
    Bandak SI, Bolzon LD, Turnak MR, Johns D, Henle SK, Allen BS.
    Int J Clin Pract; 1999 Dec; 53(8):578-83. PubMed ID: 10692750
    [Abstract] [Full Text] [Related]

  • 19. A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis.
    Brook I.
    Clin Ther; 2005 Aug; 27(8):1266-73. PubMed ID: 16199251
    [Abstract] [Full Text] [Related]

  • 20. Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
    Iravani A.
    Clin Ther; 1992 Aug; 14(1):54-63. PubMed ID: 1576626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.